FTRE Stock Analysis: Buy, Sell, or Hold?

FTRE - Fortrea Holdings Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
$17.28
-0.30 (-1.71%) ▼
5d: -2.43%
30d: +12.5%
90d: +81.7%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026

Get Alerted When FTRE Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: FTRE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$31.45
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$19.53
11.5% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: FTRE is currently trading at $17.28, which is considered extended relative to its 30-day fair value range of $15.02 to $17.32. The stock's valuation (Forward PE: 16.1) is in line with its historical norms (15.0). At these levels, the market is pricing in 2.2% annual earnings growth.

Technical Outlook: Technically, FTRE is in a strong uptrend. The price is approaching resistance at $17.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: FTRE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $15.02 - $17.32
Company Quality Score 58/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 58.1%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BEARISH: Trading above Wall St target ($16.39)
  • BULLISH: Expecting earnings turnaround to 2.2% growth with -2.3% revenue growth

Trading Range Analysis

30-Day Trading Range $15.02 - $17.32
Current vs Trading Range EXTENDED

Support & Resistance Levels

Support Level $13.11
Resistance Level $17.56
Current Trend Strong Uptrend
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) 16.05
Wall Street Target $16.39 (-5.1%)
Revenue Growth (YoY) -2.3%
Earnings Growth (YoY) -57.4%
Profit Margin -16.5%
Valuation Premium vs History +2.2% premium
PE vs Historical 16.1 vs 15.0 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +2.2% (market-implied from PE analysis)
1-Year Target $17.66 (+2%)
2-Year Target $18.05 (+4%)
3-Year Target $18.45 (+7%)
3-Yr Target (if PE normalizes) (PE: 16→15) PE COMPRESSION $17.24 (0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 21.8, Growth: 33.5%) $55.76 (+223%)
Base: (SPY PE: 16.0, Growth: 33.5%) $41.09 (+138%)
Bear: (PE: 13.6, Growth: 33.5%) $34.92 (+102%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 04, 2026 9:31 AM ET
Data refreshes hourly during market hours. Next update: 10:31 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Jill G Mcconnell SELL 1804 shares 2026-03-16
Jill G Mcconnell SELL 5061 shares 2026-03-10
Robert Parks SELL 1927 shares 2026-03-10

Unlock Insider Activity

See real-time buying/selling by company executives for FTRE.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$436 64 BUY
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
18 analysts
$257 61 BUY
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$31 58 HOLD
BHVN
Biohaven Ltd.
STRONG BUY
16 analysts
$22 57 HOLD
BEAM
Beam Therapeutics Inc
STRONG BUY
17 analysts
$51 62 BUY

More Analysis for FTRE

FTRE Technical Chart FTRE Price Prediction FTRE Earnings Date FTRE Investment Advisor FTRE Fair Price Analyzer FTRE Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals